A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants

Clinical trial NCT04960124 · COMPLETED

Trial details

NCT number: NCT04960124
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Impairment

Start date: 2021-08-05
Primary completion: 2021-11-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.